期刊文献+

高龄不稳定型心绞痛合并慢性肾病患者应用不同剂量氯吡格雷的有效性及安全性 被引量:4

Efficacy and safety of different doses of clopidogrel in treatment of elderly patients with unstable angina complicated with chronic kidney disease
下载PDF
导出
摘要 目的分析不同剂量氯吡格雷联合阿司匹林在高龄不稳定型心绞痛合并慢性肾病患者中的治疗效果。方法选取2013年1月至2015年12月收治的90例不稳定型心绞痛合并慢性肾病患者为观察对象,按照随机数字表法将患者分为对照组和观察组,每组45例。对照组患者给予口服氯吡格雷50mg/d+阿司匹林100mg/d治疗,观察组患者给予12I服氯吡格雷75mg/d+阿司匹林100mg/d治疗。连续治疗1月,对比两组疗效及药物副作用。结果观察组疗效高于对照组(97.78%比84.44%,Z=7.717,P〈0.05);观察组患者药物不良反应发生率及其肾功能变化与对照组比较差异均无统计学意义(均P〉0.05)。结论75mg/d氯吡格雷联合100mg/d阿司匹林治疗能够有效改善不稳定型心绞痛合并慢性肾病患者的临床症状,具有安全高效和副作用少等特点,值得在不稳定型心绞痛合并慢性肾病治疗中推广应用。 Objective To analyze the effects of different doses of clopidogrel combined with aspirin in the treatment of elderly patients with unstable angina complicated with chronic kidney disease. Methods From January 2013 to December 2015, 90 patients with unstable angina complicated with chronic kidney disease were selected as observation objects and divided into a control group and an observation group using random number table method, 45 cases for each group. The control group were given clopidogrel, 50 mg/d and aspirin, 100 mg/ d and the observation group 75 mg/d and 100 mg/d for 1 month. The curative effect and drug side effects were compared between these two groups. Results The curative efficacy was higher in the observation group than in the control group ( 97.78% vs. 84.44%, Z=7.717, P 〈 0.05 ) . There were no statistical differences in the incidence of adverse drug reactions and renal function between these two groups ( P 〉 0.05 ) . Conclusion Clopidogrel 75 mg/d and aspirin 100 mg/d in the treatment of elderly patients with unstable angina complicated with chronic kidney disease can effectively improve the patients' symptoms in patients with chronic nephropathy and is safe and efficient and has fewer side effects, so it is worth being generalized.
作者 李艳丽
出处 《国际医药卫生导报》 2017年第3期375-377,共3页 International Medicine and Health Guidance News
关键词 高龄 不稳定型心绞痛 慢性肾病 氯吡格雷 Advanced age Unstable angina Chronic kidney disease Clopidogrel
  • 相关文献

参考文献6

二级参考文献37

  • 1刘淑芳.低分子肝素治疗急性冠状动脉综合征患者的疗效观察[J].医学研究通讯,2005,34(3):36-37. 被引量:8
  • 2陆在英,钟南山.内科学[M].第7版.北京:人民卫生出版社,2007.
  • 3Ben-Dor I, Kleiman N S, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy [ J ]. Am J Cardiol, 2009,104 ( 2 ) : 227-233.
  • 4叶任高;陆再英.内科学[M]北京:人民卫生出版社,2004281.
  • 5Gurbel PA,Bliden KP,Hayes KM,et a1. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatnent platelet aggregation in patients undergoing coronary stenting[J].Journal of the American College of Cardiology,2005.1392-1396.
  • 6中华医学会心血管学分会,中华心血管病杂志编辑委员会.2013抗血小板治疗中国专家共识.中华心血管病杂志,2013,41:183-194.
  • 7Fox KA,Fitzgerald G,Puymirat E,et al.Should patients with acute coronary disease be stratified for management according to their risk?Derivation,external validation and outcomes using the updated GRACE risk score.BMJ Open,2014,4:e004425.
  • 8Bergmeijer TO,Janssen PW,Schipper JC,et al.CYP2C19genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI(POPular)Genetics study.Am Heart J,2014,168:16-22.
  • 9Wright RS,Anderson JL,Adams CD,et al.2011ACCF/AHA focused update incorporated into the ACC/AHA 2007Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.developed in collaboration with the American Academy of Family Physicians,Society for Cardiovascular Angiography and Interventions,and the Society of Thoracic Surgeons.J Am Coll Cardiol,2011,57:e215-e367.
  • 10Jiang XL,Samant S,Lesko LJ,et al.Clinical pharmacokinetics and pharmacodynamics of clopidogrel.Clin Pharmacokinet,2015,54:147-166.

共引文献68

同被引文献33

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部